Proto Script Pharmaceutical (Proto Script Pharmaceutical) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Proto Script Pharmaceutical's net issuance of preferred for the three months ended in Sep. 2017 was $0.00 Mil. The number is 0, which means that Proto Script Pharmaceutical has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Proto Script Pharmaceutical's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2017 was $0.00 Mil.

Proto Script Pharmaceutical Net Issuance of Preferred Stock Historical Data

The historical data trend for Proto Script Pharmaceutical's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Net Issuance of Preferred Stock Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

Net Issuance of Preferred Stock

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Proto Script Pharmaceutical Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Proto Script Pharmaceutical Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines